Table 1 Clinicopathological features of endometrioid-type endometrial carcinoma patients (n = 107)
Parameter | Number of cases (%) | |||||
|---|---|---|---|---|---|---|
Total | Stage IB | Stage IIIC/IVB | ||||
n = 107 (100) | n = 60 (100) | n = 47 (100) | ||||
Age (years) | ||||||
mean ± SD [minimum to maximum] | 62.7 ± 11.0 | [33–87] | 65.2 ± 10.7 | [33–87] | 59.4 ± 10.7 | [38–84] |
≤ 50 | 11 | (10) | 3 | (5) | 8 | (17) |
> 50 | 96 | (90) | 57 | (95) | 39 | (83) |
Histological grade | ||||||
G1 | 40 | (37) | 28 | (47) | 12 | (26) |
G2 | 38 | (36) | 22 | (37) | 16 | (34) |
G3 | 29 | (27) | 10 | (17) | 19 | (40) |
Lymphovascular invasion | ||||||
Positive | 80 | (75) | 39 | (65) | 41 | (87) |
Negative | 27 | (25) | 21 | (35) | 6 | (13) |
Lymph node metastasis | ||||||
Positive | 42 | (39) | 0 | (0) | 42 | (89) |
Negative | 65 | (61) | 60 | (100) | 5 | (11) |
Surgical therapy | ||||||
Total hysterectomy + BSO | 104 | (97) | 59 | (98) | 45 | (96) |
Total hysterectomy + LSO | 1 | (1) | 1 | (2) | 0 | (0) |
Supracervical hysterectomy+ BSO | 1 | (1) | 0 | (0) | 1 | (2) |
Supracervical hysterectomy + LSO | 1 | (1) | 0 | (0) | 1 | (2) |
Adjuvant therapy | ||||||
Chemotherapy | 79 | (74) | 43 | (72) | 36 | (77) |
Radiation | 4 | (4) | 2 | (3) | 2 | (4) |
Radiation followed by chemotherapy | 7 | (6) | 1 | (2) | 6 | (13) |
Not done | 17 | (16) | 14 | (22) | 3 | (6) |